NeuroBo Pharmaceuticals (NRBO) Earnings Date & Reports
A.I. Advisor
published Earnings
NRBO is expected to report earnings to rise 33.33% to -11 cents per share on March 29
Q4'23
Est.
$-0.12
Q3'23
Beat
by $0.02
Q2'23
Beat
by $0.11
Q1'23
Beat
by $0.53
Q4'22
Beat
by $6.13
The last earnings report on November 13 showed earnings per share of -9 cents, beating the estimate of -10 cents. With 60.72K shares outstanding, the current market capitalization sits at 28.49M.